Delivery Order SPE2DB22D9130-SPE2DB25FE0GC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on July 17, 2025. The contract calls for delivery of Stelara 90 mg/ml syringes, a biologic medication used to treat immunological conditions, with an ultimate completion date of August 7, 2025. This delivery order carries no set-aside designation and will be performed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 9, 2025. The delivery order is for Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award was issued without a set-aside designation and carries an ultimate completion date of September 30, 2025, with performance to be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $97.5K firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Stelara 90 mg/mL syringes. The contract carries an ultimate completion date of October 2, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 12, 2025. This delivery order, without set-aside designation, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare requirements. The award is expected to be completed by October 3, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 8, 2025. This firm fixed-price delivery order is for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of August 29, 2025. The contract utilizes no set-aside designation, demonstrating the company's competitive positioning in federal procurement markets. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on July 24, 2025. The delivery order, issued under the SPE2DB Indefinite Delivery Contract program (valued at $499,999,999 through November 2026), calls for the delivery of Stelara 90 mg/mL syringes to support Department of Defense medical supply requirements. The contract carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $16,249.95 from the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, issued without set-aside designation, covers the supply of Stelara 90 mg/mL syringes to support military healthcare operations. This award represents a single task order executed under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 18, 2025. The delivery order calls for the supply of Stelara 90 mg/ml syringes, a biologic immunosuppressant medication used primarily for treating autoimmune conditions. This award was issued without a set-aside designation, and performance is scheduled for completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,220.68 by the Defense Logistics Agency on March 18, 2025. The award covers the supply of Stelara 90 mg/ml syringes, a biologic medication used primarily for treating autoimmune conditions. This delivery order was issued without a set-aside designation and is scheduled for completion by April 8, 2025, with performance...
- SPE2DB22D9130Indefinite Delivery Contract
- SPE2DB22D9130-SPE2DB25FE0GCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 18, 2025. The contract, which has no set-aside designation, calls for the delivery of Stelara 90 mg/ml syringes, a biologic medication commonly used to treat autoimmune conditions. Performance is scheduled for completion by October 9, 2025, with fulfillment taking place at the contractor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. This IDC establishes the company as a key supplier of pharmaceutical products to military healthcare facilities nationwide, enabling the issuance of firm fixed-price delivery orders across a comprehensive portfolio of prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group has maintained a robust history of federal pharmaceutical supply contracts since its SAM.gov registration in 2001, positioning it as a critical component of the Department of Defense's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/18/25 |